Metformin-loaded Chitosan nanoparticles alleviate insulin resistance in the polycystic ovarian syndrome rat model through modulation of PI3K/AKT/ GLUT4 in ovarian tissue
Abstract
Polycystic ovary syndrome (PCOS) is a common disorder in females characterized by insulin resistance (IR), hyperandrogenemia and anovulation. The etiology of PCOS is unknown. However, disrupted phosphatidylinositol 3-kinase (PI3K) and protein kinase B/AKT signaling pathway may be a possible cause of IR in PCOS. Metformin can activate AKT via PI3K and improve IR. However, metformin alone has shown conflicting results. Chitosan nanoparticles (CSNPs) are natural nano-carriers with anti-diabetic effects. Therefore, we aimed to elucidate the therapeutic potential of metformin-loaded CSNPs (CSNPs-Met) in a letrozole-induced PCOS rat model. The study comprised five groups of rats: control, PCOS, PCOS plus metformin, PCOS plus CSNPs, and PCOS plus CSNPs-Met. Letrozole was found to successfully induce PCOS, as evidenced by elevated serum testosterone levels, homeostasis model assessment-insulin resistance (HOMA-IR), an increased number of cystic follicles, fewer corpora lutea and a disturbed estrus cycle. The pAKT and GLUT4 protein levels were significantly lower in ovarian and muscular tissues than in control group (P < 0.001), suggesting impaired insulin signaling and glucose transport that may contribute to both the metabolic and reproductive disturbances. CSNP-Met showed a significant decrease in testosterone, HOMA-IR, cystic follicles with an increase in the number of corpora lutea, as well as the levels of pAKT and GLUT4 in ovarian and muscular tissues (P < 0.001). In addition,…
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.